Payers

At NAACOS Meeting, Gaus, Brooks-LaSure Discuss Equity, Payments, Messaging

September 8th 2022, 8:35pm

Effective messaging about the value of accountable care organizations (ACOs) is a key strategy if both CMS and the National Association of ACOs are to hit lofty goals, the leaders of both organizations said Thursday.

Neil Goldfarb on Theme, Potential Insights of 2022 GPBCH Wellness Summit

September 8th 2022, 4:10pm

Neil Goldfarb, president and CEO of the Greater Philadelphia Business Coalition on Health (GPBCH), reviews the key topics to be addressed at the 2022 GPBCH Wellness Summit.

Gap After OCM May Cause Some Practices to Switch From Biosimilars to Brand Drugs

September 1st 2022, 1:53pm

The 1-year gap after the end of the Oncology Care Model (OCM) means some practices have to make hard decisions regarding cost of care or the financial health of the practice, explained Lalan Wilfong, MD, vice president of Payer Relations & Practice Transformation at The US Oncology Network.

Provider and Payer Demand Largely Drives Biosimilar Adoption to Institution Formularies

August 29th 2022, 12:59pm

Having a biosimilar on formulary makes it more likely the biosimilar will be adopted. Length of time a biosimilar is on market can impact how likely it is to be added to formulary.

High-Concentration Version of Adalimumab Biosimilar Will Be Available in 2023

August 23rd 2022, 4:00pm

The FDA approved the first high-concentration adalimumab biosimilar. A low-concentration version of the biosimilar, Hadlima, was already approved. Both versions will launch in July 2023.

Teleophthalmology Is Here Today, but Insurance Coverage, Reimbursement Will Change

August 17th 2022, 1:13pm

Insurance reimbursement for teleophthalmology services is not consistent among populations and only recently received a boost due to flexibilities allowed during the pandemic, said Parisa Emami-Naeini, MD, MPH, assistant professor of ophthalmology at University of California, Davis, and vitreoretinal surgeon and uveitis specialist at UC Davis Eye Center.

Shifting Landscape of Care Delivery Is Impacting Value-Based Cancer Care

August 16th 2022, 7:02pm

The Institute for Value-Based Medicine series visits Texas Oncology in Austin.

How Advocacy Groups and Patient Data Can Help Drive Health Equity

August 15th 2022, 9:15pm

New Enhancing Oncology Model Builds on Knowledge From the OCM

August 15th 2022, 7:12pm

OCM Successor Puts Focus on Equity in Cancer Care—With Fewer Dollars for Services

August 15th 2022, 6:50pm